Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Brain Ischemia D002545 89 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Hyperlipidemias D006949 73 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia P388 D007941 43 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Ohnhaus EE et al. Enzyme induction and renal function in man. 1977 Br J Clin Pharmacol pmid:843422
Jackson L et al. The features of hepatic enzyme induction with glutethimide in man. 1978 Br J Clin Pharmacol pmid:728322
Latham AN Effect of data transformation on t-test sensitivity. 1978 Br J Clin Pharmacol pmid:728324
Tokola O et al. Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. 1975 Br J Clin Pharmacol pmid:786355
Heinemeyer G et al. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy. 1986 Br J Clin Pharmacol pmid:2868749
Price DE et al. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. 1986 Br J Clin Pharmacol pmid:3567022
Perucca E et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. 1984 Br J Clin Pharmacol pmid:6435654
Barot MH et al. Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy. 1978 Br J Clin Pharmacol pmid:687505
May G Tetrachlorodibenzodioxin: a survey of subjects ten years after exposure. 1982 Br J Ind Med pmid:6121580
Martin JV Lipid abnormalities in workers exposed to dioxin. 1984 Br J Ind Med pmid:6232943
Edwards JW and Priestly BG Sister chromatid exchanges in lymphocytes of petroleum retailers. 1993 Br J Ind Med pmid:8435347
Moretto A and Lotti M Exposure to toluene increases the urinary excretion of D-glucaric acid. 1990 Br J Ind Med pmid:2310708
Edwards TJ et al. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. 2009 Br J Surg pmid:19731228
Simpson JA et al. Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069594
Ranganathan P and Pramesh CS Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069595
Hunter J et al. Altered calcium metabolism in epileptic children on anticonvulsants. 1971 Br Med J pmid:5115570
Maxwell JD et al. Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction? 1972 Br Med J pmid:5008482
NISSIM JA Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations. 1954 Br Med J pmid:13115719
Roberts C et al. Glutethimide and enzyme induction. 1976 Br Med J pmid:990872
BOYLAND E et al. Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds. 1957 Br. J. Cancer pmid:13510516
Okada S et al. Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. 1989 Br. J. Cancer pmid:2803947
Beshara S et al. Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. 2003 Br. J. Haematol. pmid:12614222
Perewusnyk G et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. 2002 Br. J. Nutr. pmid:12117422
Laidlaw M et al. Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial. 2010 Breast Cancer (Auckl) pmid:21234288
Kimbrough RD The epidemiology and toxicology of TCDD. 1984 Bull Environ Contam Toxicol pmid:6240288
Sartor P and Cohere G [Iron saccharate capture by rat uterus epithelium. Experimental study with respect to hormonal status]. 1973 C. R. Seances Soc. Biol. Fil. pmid:4794498
Hornez JP et al. [Demonstration of different metabolic pathways starting with glucose or fructose in Rhizobium meliloti]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:11894
Hoffmann D [Role of phagocytosis and soluble antibacterial factors in experimental immunization of Locusta migratoria]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:821627
DEVOE RW and MOSES LE Iron therapy in pregnancy; a comparative study of various modes. 1954 Calif Med pmid:13209356
Karkouti K et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. 2006 Can J Anaesth pmid:16371604
CAMERON DG et al. Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity. 1951 Can Med Assoc J pmid:14792459
CAMERON DG et al. Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route. 1951 Can Med Assoc J pmid:14792458
Latham AN et al. Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man. 1976 Can. J. Physiol. Pharmacol. pmid:991005
Latham AN and Sweeney GD Binding of anticonvulsant drugs to cytochrome P-450: correlation with evidence of induction of hepatic microsomal enzymes. 1976 Can. J. Physiol. Pharmacol. pmid:1021219
Perek N et al. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. 2005 Cancer Biother. Radiopharm. pmid:16114987
Schmittgen TD et al. Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants. 1992 Cancer Chemother. Pharmacol. pmid:1586977
Walaszek Z et al. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. 1997 Cancer Detect. Prev. pmid:9101079
Walaszek Z Potential use of D-glucaric acid derivatives in cancer prevention. 1990 Cancer Lett. pmid:2208084
Walaszek Z et al. Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland. 1990 Cancer Lett. pmid:2302696
Walaszek Z et al. Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis. 1986 Cancer Lett. pmid:3768860
Oredipe OA et al. Effects of calcium glucarate on the promotion of diethylnitrosamine-initiated altered hepatic foci in rats. 1987 Cancer Lett. pmid:3690519
Wang CY and Hayashida S Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats. 1984 Cancer Lett. pmid:6548659
Kowalczyk MC et al. Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. 2010 Cancer Prev Res (Phila) pmid:20103723
Newman MA et al. Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine. 1990 Cancer Res. pmid:2334930
Liddil JD et al. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells. 1989 Cancer Res. pmid:2713856
Steele VE et al. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. 1990 Cancer Res. pmid:2138505
Minami D et al. Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. 2015 Cancer Sci. pmid:26211743
Palmer K et al. Review of available intravenous iron preparations in hemodialysis. 2013 Apr-Jun CANNT J pmid:24069699
Smith TN et al. Modifications in the nitric acid oxidation of D-glucose. 2012 Carbohydr. Res. pmid:22285512
Merbouh N et al. Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. 2001 Carbohydr. Res. pmid:11675028